Konstantinos Giannakou

PhD-trained epidemiologist with 10+ years of cross-sector experience across academia, healthcare, CRO, biotech, and corporate environments. Combines MBA-level business acumen with a PhD in Public Health to drive strategic growth, innovation management, and research-driven development. Recognized subject matter expert in chronic disease epidemiology, multimorbidity, and lifestyle-related health determinants, with a strong emphasis on oncology, metabolic, and kidney disease outcomes. Interested in vaccination behaviors, health inequalities, and cognitive impairment, aiming to generate real-world evidence that informs clinical practice, health policy, and patient-centered care. Strong track record in designing and leading multi-country observational studies, clinical registries, interventional and real-world studies as well as advanced evidence-synthesis studies. Proven expertise in protocol and SAP development, feasibility assessment, database analysis, and dissemination of real-world evidence for academic, commercial, and regulatory stakeholders. Author of 100+ peer-reviewed publications with contributions to international guidelines, policy briefs, and health authority consultations. Experienced in leading cross-functional teams, securing and managing funded projects, scaling operations, and delivering client- and stakeholder-facing scientific communication.